1. Home
  2. LSAK vs RZLT Comparison

LSAK vs RZLT Comparison

Compare LSAK & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lesaka Technologies Inc.

LSAK

Lesaka Technologies Inc.

HOLD

Current Price

$4.76

Market Cap

411.8M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$5.04

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSAK
RZLT
Founded
1997
2010
Country
South Africa
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.8M
420.8M
IPO Year
2005
2011

Fundamental Metrics

Financial Performance
Metric
LSAK
RZLT
Price
$4.76
$5.04
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.67
AVG Volume (30 Days)
121.4K
2.3M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
$659,701,000.00
N/A
Revenue This Year
$14.35
N/A
Revenue Next Year
$8.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.92
N/A
52 Week Low
$3.62
$1.07
52 Week High
$5.54
$11.46

Technical Indicators

Market Signals
Indicator
LSAK
RZLT
Relative Strength Index (RSI) 45.77 57.57
Support Level $4.48 $2.91
Resistance Level $5.05 $5.42
Average True Range (ATR) 0.12 0.34
MACD -0.01 -0.07
Stochastic Oscillator 33.81 67.19

Price Performance

Historical Comparison
LSAK
RZLT

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: